India approves its first nasal vaccine for COVID-19 | Daily News

India approves its first nasal vaccine for COVID-19

US eyes annual COVID-19 shots

INDIA: India on Tuesday approved a locally developed, needle-free and nasally administered COVID-19 vaccine for emergency use, in a boost to the country’s homegrown pharmaceutical industry.

The new inoculation was developed by Bharat Biotech, which had already developed an intravenous product greenlit by the World Health Organization last November.

India’s drug regulator gave the new product emergency authorization on Tuesday, which will allow it to be used as a primary dose by any unvaccinated or partially vaccinated adult, but not as a booster.

“This step will further strengthen our collective fight against the pandemic,” Health Minister Mansukh Mandaviya said on Twitter.

The announcement comes just two days after China launched the world’s first inhalable coronavirus vaccine, Convidecia Air, which is administered through a nebulizer.

India has since administered more than two billion vaccine doses, fully inoculating more than two-thirds of its 1.4 billion population.

Meanwhile, The United States is likely to start recommending COVID-19 vaccines annually, health officials said on Tuesday, as new boosters designed to fight currently circulating variants of the coronavirus roll out.

President Joe Biden said separately in a statement that for most Americans, “that means one COVID-19 shot, once a year, each fall.”

Top U.S. infectious disease expert Dr. Anthony Fauci said unless a dramatically different variant emerges, annual vaccines should offer enough protection for most people, but that some vulnerable groups might need more frequent vaccinations.



Add new comment